Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Ventas Inc. (NYSE:VTR) is a real estate investment trust, which owns, develops, and manages a diverse portfolio of properties such as senior housing communities, outpatient medical buildings, research centers, hospitals, and healthcare facilities.
The company’s stock traded at approximately $72.75 per share 10 years ago. If you had invested $10,000, you could have bought roughly 137 shares. Currently, shares trade at $63.45, meaning your investment’s value could have declined to $8,738 from stock price depreciation. However, Ventas also paid dividends during these 10 years.
Don’t Miss:
Ventas’ dividend yield is currently 3.06%. Over the last 10 years, it has paid about $25.55 in dividends per share, which means you could have made $3,512 from dividends alone.
Summing up $8,738 and $3,512, we end up with the final value of your investment, which is $12,250. This is how much you could have made if you had invested $10,000 in Ventas stock 10 years ago. This means a total return of 22.50%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 241%.
Ventas has a consensus rating of “Outperform” and a price target of $60.35 based on the ratings of 28 analysts. The price target implies a nearly 5% potential downside from the current stock price.
Trending: Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.
On April 30, the company announced its Q1 2025 earnings, posting FFO of $0.84, compared to the consensus estimate of $0.82, and revenues of $1.36 billion, compared to the consensus of $1.32 billion, as reported by Benzinga.
“Ventas delivered a strong first quarter of 2025, as we executed on our strategy to capitalize on the unprecedented multiyear growth opportunity in senior housing. We drove double-digit growth in our senior housing operating portfolio, which powered our first quarter results,” said CEO Debra A. Cafaro.
The company reaffirmed its full-year 2025 guidance, expecting normalized FFO per share in the range of $3.35 to $3.46.
